Keryx Biopharma (KERX) Reports Q1 Loss of 13c/Share, Misses by 1c
Tweet Send to a FriendGet Alerts KERX Hot Sheet
Price: $8.05 +1.39%
EPS Growth %: +76.9%
Financial Fact:
Interest and other income, net: 103K
Today's EPS Names:
SNPS, SPTN, GAME, More
EPS Growth %: +76.9%
Financial Fact:
Interest and other income, net: 103K
Today's EPS Names:
SNPS, SPTN, GAME, More
Trade KERX Now!
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) reported Q1 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- China Digital TV Holding Co. (STV) Improves Q1 EPS to 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
